BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26219)

  • 1. Drug therapy in the treatment of minimal brain dysfunction.
    Saccar CL
    Am J Hosp Pharm; 1978 May; 35(5):544-52. PubMed ID: 26219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative analysis of antidepressants and stimulants for the treatment of adults with attention-deficit hyperactivity disorder.
    Higgins ES
    J Fam Pract; 1999 Jan; 48(1):15-20. PubMed ID: 9934377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal brain dysfunction.
    Piepho RW; Gourley DR; Hill JW
    J Am Pharm Assoc; 1977 Aug; 17(8):500-4. PubMed ID: 19519
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C; Boidein F
    Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition and treatment of attention deficit disorder.
    Bond WS
    Clin Pharm; 1987 Aug; 6(8):617-24. PubMed ID: 2891464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
    Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
    Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond methylphenidate: nonstimulant medications for youth with ADHD.
    Wood JG; Crager JL; Delap CM; Heiskell KD
    J Atten Disord; 2007 Nov; 11(3):341-50. PubMed ID: 17932386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychopharmacology of ADHD in adolescents.
    Greydanus DE; Sloane MA; Rappley MD
    Adolesc Med; 2002 Oct; 13(3):599-624. PubMed ID: 12270803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged P300 latency in attention deficit hyperactivity disorder predicts poor response to imipramine.
    Sangal JM; Sangal RB; Persky B
    Clin Electroencephalogr; 1996 Oct; 27(4):191-201. PubMed ID: 9465283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of attention-deficit/hyperactivity treatment and diagnosis methods tested.
    Rep Med Guidel Outcomes Res; 2000 Feb; 11(4):1-2, 5-7. PubMed ID: 11768409
    [No Abstract]   [Full Text] [Related]  

  • 11. Co-morbidity and treatment of attention deficit hyperactivity disorder in Saudi Arabia.
    Al-Haidar FA
    East Mediterr Health J; 2003; 9(5-6):988-95. PubMed ID: 16450529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulants and antidepressant pharmacokinetics in hyperactive children.
    Elia J
    Psychopharmacol Bull; 1991; 27(4):411-5. PubMed ID: 1687612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attention deficit hyperactivity disorder across the lifespan: the child, adolescent, and adult.
    Greydanus DE; Pratt HD; Patel DR
    Dis Mon; 2007 Feb; 53(2):70-131. PubMed ID: 17386306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attention-deficit/hyperactivity disorder: a neuropsychiatric disorder with childhood onset.
    Zuddas A; Ancilletta B; Muglia P; Cianchetti C
    Eur J Paediatr Neurol; 2000; 4(2):53-62. PubMed ID: 10817485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attention-deficit hyperactivity disorder.
    Calis KA; Grothe DR; Elia J
    Clin Pharm; 1990 Aug; 9(8):632-42. PubMed ID: 1974836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of treatment refractory attention-deficit/hyperactivity disorder in children and adolescents.
    Wagner KD
    Psychopharmacol Bull; 2002; 36(1):130-42. PubMed ID: 12397852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attention-deficit hyperactivity disorder: the pharmacist's role.
    Levin GM
    Am Pharm; 1995 Nov; NS35(11):10-20. PubMed ID: 8533716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric psychopharmacology. A review with special reference to deanol.
    Oettinger L
    Dis Nerv Syst; 1977 Dec; 38(12 Pt 2):25-31. PubMed ID: 338271
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacologic alternatives to psychostimulants for the treatment of attention-deficit/hyperactivity disorder.
    Popper CW
    Child Adolesc Psychiatr Clin N Am; 2000 Jul; 9(3):605-46, viii. PubMed ID: 10944659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to growth hormone in attention deficit hyperactivity disorder: effects of methylphenidate and pemoline therapy.
    Rao JK; Julius JR; Breen TJ; Blethen SL
    Pediatrics; 1998 Aug; 102(2 Pt 3):497-500. PubMed ID: 9685452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.